ANI PHARMACEUTICALS INC 8-K

What Happened

• ANI Pharmaceuticals, Inc. (ANIP) filed a Form 8-K on May 13, 2026 (Item 7.01) announcing it has published an updated investor presentation to the investor relations section of its website. The company said it may use this updated presentation in meetings with investors and analysts from time to time. A copy of the presentation is attached to the filing as Exhibit 99.1.

Key Details

• Filing date: May 13, 2026 (Form 8-K).
• The investor presentation is dated May 2026 and has been posted to the company’s investor relations website.
• The presentation is included as Exhibit 99.1 to the 8-K; the filing also includes the interactive Inline XBRL cover page (Exhibit 104).
• The disclosure was made under Regulation FD (Item 7.01); no earnings, executive changes, mergers, or other material events were reported in this filing.

Why It Matters

• The updated investor presentation is the company’s most recent official investor materials and may contain refreshed strategic, operational, or financial slide content investors and analysts will use to evaluate ANIP. Because the disclosure was made under Regulation FD, the information is intended to be broadly available to all investors at the same time.
• Retail investors should review the posted presentation on ANIP’s investor relations site for any new details relevant to investment decisions; the 8-K itself does not provide additional financial results or forward guidance.